Ligand-activated Ahr signaling leads to disruption of nephrogenesis and altered Wilms' tumor suppressor mRNA splicing

被引:30
作者
Falahatpisheh, MH [1 ]
Ramos, KS [1 ]
机构
[1] Texas A&M Univ, Ctr Environm & Rural Hlth, College Stn, TX 77843 USA
关键词
Ahr; WT1; splicing; nephrogenesis;
D O I
10.1038/sj.onc.1206238
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aryl hydrocarbon receptor (Ahr), a member of the large basic helix-loop-helix (bHLH) and PAS homology domain superfamily, is a highly conserved transcriptional regulator involved in mammalian development. In the present study, a murine metanephros organ culture system was employed to evaluate the role of the Ahr signaling in nephrogenesis in vitro. Ahr and Wilms' tumor suppressor (wt1) mRNAs were detected by in situ hybridization and RT-PCR during the course of renal development. Treatment with 3 pm BaP, a hydrocarbon ligand of Ahr, inhibited glomerulogenesis and branching morphogenesis of metanephric kidneys. Deficits in the epithelialization of mesenchymal cells were evidenced by inhibition of the formation of podocyte foot processes and glomerular basement membranes. Hydrocarbon treatment markedly induced -KTS wt1 splice variants, although total wt1 mRNA levels remained unchanged. A significant decrease in total WT1 protein was observed by both immunocytochemistry and Western analysis in cultures challenged with BaP compared to controls. Comparison of metanephric cultures from Ahr+/+ and Ahr-/- mice showed that Ahr is involved in kidney development, and required for BaP-induced deficits in nephrogenesis. These results indicate that ligand activation of Ahr signaling disrupts nephrogenesis in vitro, and that this response involves modulation of wt1 alternative splicing and post-transcriptional control.
引用
收藏
页码:2160 / 2171
页数:12
相关论文
共 48 条
[1]   Review of the interaction between TCDD and glucocorticoids in embryonic palate [J].
Abbott, BD .
TOXICOLOGY, 1995, 105 (2-3) :365-373
[2]  
ASWIN M, 1998, KIDNEY INT, V53, P1512
[3]   POLYPEPTIDE GROWTH-FACTORS IN METANEPHRIC GROWTH AND SEGMENTAL NEPHRON DIFFERENTIATION [J].
AVNER, ED ;
SWEENEY, WE .
PEDIATRIC NEPHROLOGY, 1990, 4 (04) :372-377
[4]  
AVNER ED, 1993, SEMIN NEPHROL, V13, P427
[5]   Donor splice-site mutations in WT1 are responsible for Frasier syndrome [J].
Barbaux, S ;
Niaudet, P ;
Gubler, MC ;
Grunfeld, JP ;
Jaubert, F ;
Kuttenn, F ;
Fekete, CN ;
SouleyreauTherville, N ;
Thibaud, E ;
Fellous, M ;
McElreavey, K .
NATURE GENETICS, 1997, 17 (04) :467-470
[6]   Atypical cytochrome P450 induction profiles in glomerular mesangial cells at the mRNA and enzyme level - Evidence for CYP1A1 and CYP1B1 expression and their involvement in benzo[a]pyrene metabolism [J].
Bowes, RC ;
Parrish, AR ;
Steinberg, MA ;
Willett, KL ;
Zhao, W ;
Savas, U ;
Jefcoate, CR ;
Safe, SH ;
Ramos, KS .
BIOCHEMICAL PHARMACOLOGY, 1996, 52 (04) :587-595
[7]   ASSESSMENT OF CELL-SPECIFIC CYTOTOXIC RESPONSES OF THE KIDNEY TO SELECTED AROMATIC-HYDROCARBONS [J].
BOWES, RC ;
RAMOS, KS .
TOXICOLOGY IN VITRO, 1994, 8 (06) :1151-1160
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]   A non-AUG translational initiation event generates novel WT1 isoforms [J].
Bruening, W ;
Pelletier, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (15) :8646-8654
[10]   Correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced apoptotic cell death in the embryonic vasculature with embryotoxicity [J].
Cantrell, SM ;
Joy-Schlezinger, J ;
Stegeman, JJ ;
Tillitt, DE ;
Hannink, M .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 148 (01) :24-34